← Leaderboards
Gregory S Karczmar
$21,435,905
Attributed
$31,988,985
Total exposure
25
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,488,985 · 26
By mechanism
R01$18,665,773 · 9
S10$3,487,700 · 4
U01$2,275,583 · 1
UT2$2,049,960 · 1
P50$1,439,397 · 1
R33$1,140,685 · 1
Top collaborators
- Aytekin Oto13 shared
- Rita Nanda6 shared
- Richard G Abramson5 shared
- Vandana Abramson5 shared
- Gillian Newstead5 shared
- David Schacht5 shared
- Thomas E Yankeelov5 shared
- Hiroyuki Abe3 shared
Others in their field
Top investigators on “Magnetic Resonance Imaging”
- Michael W Weiner · Northern California Institute Res &Educ$151,227,246
- Paul S. Aisen · Cognition Therapeutics, Inc.$114,102,468
- Reisa A. Sperling · Banner Health$112,709,449
- Randall J Bateman · Washington University$108,056,165
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
Magnetic Resonance ImagingImageMalignant NeoplasmsBaseResolutionMeasurementMalignant Breast NeoplasmEvaluationDiagnostic AccuracyClinical TrialsScreeningLaboratoriesTissuesTumorDiagnosisScanningFundingChicagoNovel StrategiesContrast MediaBreastPhysiologicalWomanEarly Diagnosis
Grant awards (90)
The Funding Mechanism of the Pilot Trial$1,255,179
R01 · FY2025 · CA
Chicago Alternative Prevention Study for BReast CAncer in Diverse Populations of High-Risk Women (CAPSBRACA)$1,167,195
R01 · FY2024 · CA
Chicago Alternative Prevention Study for BReast CAncer in Diverse Populations of High-Risk Women (CAPSBRACA)$1,268,206
R01 · FY2023 · CA
MRI Virtual Pathology of the Prostate: Multi-center multi-vendor application and validation$1,025,457
UT2 · FY2023 · CA
Detection of prostate Cancer Specific Signals with Hybrid Multi-Dimensional MRI$524,826
R01 · FY2023 · CA
MRI Virtual Pathology of the Prostate: Multi-center multi-vendor application and validation$1,024,503
UT2 · FY2022 · CA
Detection of prostate Cancer Specific Signals with Hybrid Multi-Dimensional MRI$523,484
R01 · FY2022 · CA
Advanced Imaging$53,257
P30 · FY2022 · CA · contact PI
Breast Cancer Screening with Quantitative Ultra-Fast DCEMRI and Clinical Risk Assessment$576,596
R01 · FY2021 · CA · contact PI
Detection of prostate Cancer Specific Signals with Hybrid Multi-Dimensional MRI$532,858
R01 · FY2021 · CA
Advanced Imaging$53,569
P30 · FY2021 · CA · contact PI
Breast Cancer Screening with Quantitative Ultra-Fast DCEMRI and Clinical Risk Assessment$576,596
R01 · FY2020 · CA · contact PI
Detection of prostate Cancer Specific Signals with Hybrid Multi-Dimensional MRI$530,441
R01 · FY2020 · CA
Project 2$249,666
P20 · FY2020 · CA · contact PI
MR Virtual Pathology of the Prostate$225,000
R41 · FY2020 · CA
Advanced Imaging$53,569
P30 · FY2020 · CA · contact PI
Advanced Imaging$4,735
P30 · FY2020 · CA · contact PI
Breast Cancer Screening with Quantitative Ultra-Fast DCEMRI and Clinical Risk Assessment$559,298
R01 · FY2019 · CA · contact PI
Detection of prostate Cancer Specific Signals with Hybrid Multi-Dimensional MRI$543,654
R01 · FY2019 · CA
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy$426,704
U01 · FY2019 · CA
Project 2$242,175
P20 · FY2019 · CA · contact PI
Breast Cancer Screening with Quantitative Ultra-Fast DCEMRI and Clinical Risk Assessment$87,997
R01 · FY2019 · CA · contact PI
Advanced Imaging$53,569
P30 · FY2019 · CA · contact PI
Breast Cancer Screening with Quantitative Ultra-Fast DCEMRI and Clinical Risk Assessment$576,596
R01 · FY2018 · CA · contact PI
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy$461,172
U01 · FY2018 · CA
Project 2$249,666
P20 · FY2018 · CA · contact PI
Breast Cancer Screening with Quantitative Ultra-Fast DCEMRI and Clinical Risk Assessment$90,720
R01 · FY2018 · CA · contact PI
Advanced Imaging$51,994
P30 · FY2018 · CA · contact PI
Advanced Imaging$2,727
P30 · FY2018 · CA · contact PI
Advanced Imaging$2,620
P30 · FY2018 · CA · contact PI
Breast Cancer Screening with Quantitative Ultra-Fast DCEMRI and Clinical Risk Assessment$578,205
R01 · FY2017 · CA · contact PI
Assessment of Breast Cancer Risk with High Spectral and Spatial Resolution MRI$488,977
R01 · FY2017 · CA · contact PI
Quantitative DCEMRI of Prostate Cancer Correlation with Gold Standards$465,411
R01 · FY2017 · CA · contact PI
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy$461,999
U01 · FY2017 · CA
Assessment of Breast Cancer Risk with High Spectral and Spatial Resolution MRI$488,977
R01 · FY2016 · CA · contact PI
Quantitative DCEMRI of Prostate Cancer Correlation with Gold Standards$464,511
R01 · FY2016 · CA · contact PI
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy$462,791
U01 · FY2016 · CA
Assessment of Breast Cancer Risk with High Spectral and Spatial Resolution MRI$488,977
R01 · FY2015 · CA · contact PI
Quantitative DCEMRI of Prostate Cancer Correlation with Gold Standards$463,634
R01 · FY2015 · CA · contact PI
MRI of Early Non-invasive Rodent Mammary Cancers$322,951
R01 · FY2015 · CA · contact PI
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy$293,260
U01 · FY2015 · CA
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy$169,657
U01 · FY2015 · CA
3T MRI Scanner for multidisciplinary imaging and image-guided therapy$2,000,000
S10 · FY2014 · OD · contact PI
Assessment of Breast Cancer Risk with High Spectral and Spatial Resolution MRI$474,308
R01 · FY2014 · CA · contact PI
Quantitative DCEMRI of Prostate Cancer Correlation with Gold Standards$450,471
R01 · FY2014 · CA · contact PI
MRI of Early Non-invasive Rodent Mammary Cancers$313,284
R01 · FY2014 · CA · contact PI
Assessment of Breast Cancer Risk with High Spectral and Spatial Resolution MRI$495,202
R01 · FY2013 · CA · contact PI
Quantitative DCEMRI of Prostate Cancer Correlation with Gold Standards$471,721
R01 · FY2013 · CA · contact PI
MRI of Early Non-invasive Rodent Mammary Cancers$303,616
R01 · FY2013 · CA · contact PI
In Vivo Measurements of Physiologically-evoked Neuronal Currents$218,240
R21 · FY2013 · EB · contact PI
MRI of Early Non-invasive Rodent Mammary Cancers$323,017
R01 · FY2012 · CA · contact PI
MRIS$140,059
P30 · FY2012 · CA · contact PI
MRI of Early Non-invasive Rodent Mammary Cancers$337,038
R01 · FY2011 · CA · contact PI
MRIS$146,871
P30 · FY2011 · CA · contact PI
Specificity of MRI with optimal temporal, spatial, and spectral samp. for early B$317,251
P50 · FY2010 · CA · contact PI
MRIS$159,936
P30 · FY2010 · CA · contact PI
Microvessel Density With High Spectral/Spatial MRI$376,222
R33 · FY2009 · CA · contact PI
Specificity of MRI with optimal temporal, spatial, and spectral samp. for early B$317,168
P50 · FY2009 · CA · contact PI
MRIS$146,147
P30 · FY2009 · CA · contact PI
Microvessel Density With High Spectral/Spatial MRI$365,264
R33 · FY2008 · CA · contact PI
Specificity of MRI with optimal temporal, spatial, and spectral samp. for early B$309,081
P50 · FY2008 · CA · contact PI
MRIS$92,253
P30 · FY2008 · CA · contact PI
Microvessel Density With High Spectral/Spatial MRI$399,199
R33 · FY2007 · CA · contact PI
Specificity of MRI with optimal temporal, spatial, and spectral samp. for early B$309,081
P50 · FY2007 · CA · contact PI
Fast Spectroscopic MR Imaging of Breast Cancer$240,393
R01 · FY2007 · CA · contact PI
A 7 Tesla magnet for the University of Chicago MRI research scanner$500,000
S10 · FY2006 · RR · contact PI
A7 TESLA MAGNET/UNIVERSITY CHICAGO MRI RESEARCH SCANNER$500,000
S10 · FY2006 · RR · contact PI
High Spectral/Spatial Resolution Imaging Breast Cancer$301,555
R01 · FY2006 · EB · contact PI
Fast Spectroscopic MR Imaging of Breast Cancer$247,573
R01 · FY2006 · CA · contact PI
Dynamic Spatial and Spectral, Contrast Enhanced MRI of *$193,362
R21 · FY2006 · CA · contact PI
Specificity of MRI with optimal temporal, spatial, and spectral samp. for early B$186,816
P50 · FY2006 · CA · contact PI
High Spectral/Spatial Resolution Imaging Breast Cancer$308,813
R01 · FY2005 · EB
Fast Spectroscopic MR Imaging of Breast Cancer$253,531
R01 · FY2005 · CA
Dynamic Spatial &Spectral, Contrast Enhanced MRI of Bre$196,725
R21 · FY2005 · CA
Microvessel Density With High Spectral/Spatial MRI$163,777
R21 · FY2005 · CA
High Spectral/Spatial Resolution Imaging Breast Cancer$308,813
R01 · FY2004 · EB
Fast Spectroscopic MR Imaging of Breast Cancer$253,531
R01 · FY2004 · CA
High Spectral/Spatial Resolution Imaging Breast Cancer$308,813
R01 · FY2003 · EB
High Spectral &Spatial Resolution MRI of Rodent Tumors$184,455
R21 · FY2003 · CA
High Spectral &Spatial Resolution MRI of Rodent Tumors$181,530
R21 · FY2002 · CA
NMR BOLD WITH EPR IMAGES AND 02 ELECTRODES$173,158
P41 · FY2002 · RR
Core--Magnetic resonance imaging and spectroscopy$0
P30 · FY2002 · CA
Core--Magnetic resonance imaging and spectroscopy$0
P30 · FY2002 · CA
UPGRADE FOR 4.7 TESLA MR SCANNER$487,700
S10 · FY2001 · RR
FAST SPECTROSCOPIC MR IMAGING OF BREAST CANCER$187,771
R01 · FY2001 · CA
NMR BOLD WITH EPR IMAGES AND 02 ELECTRODES$173,158
P41 · FY2001 · RR
EFFECTS OF RADIOSENSITIZERS MEASURED BY MRI$163,784
R01 · FY2001 · CA
FAST SPECTROSCOPIC MR IMAGING OF BREAST CANCER$186,101
R01 · FY2000 · CA
EFFECTS OF RADIOSENSITIZERS MEASURED BY MRI$161,149
R01 · FY2000 · CA
NMR BOLD WITH EPR IMAGES AND 02 ELECTRODES$17,669
P41 · FY2000 · RR